The FDA has approved Susvimo (ranibizumab injection) for the treatment of patients with diabetic macular edema.
Clinical Trials Arena on MSN3d
Regeneron’s macular oedema therapy shows promise in Phase III trialIn the trial, subjects treated with the Eylea HD 8mg injection every eight weeks showed non-inferior visual acuity gains.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback